These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 17332363)
21. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II. Page JM; Merkel AR; Ruppender NS; Guo R; Dadwal UC; Cannonier S; Basu S; Guelcher SA; Sterling JA Biomaterials; 2015 Sep; 64():33-44. PubMed ID: 26115412 [TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Guise TA; Yin JJ; Thomas RJ; Dallas M; Cui Y; Gillespie MT Bone; 2002 May; 30(5):670-6. PubMed ID: 11996903 [TBL] [Abstract][Full Text] [Related]
23. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta in osteolytic breast cancer bone metastases. Guise TA; Chirgwin JM Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590 [TBL] [Abstract][Full Text] [Related]
25. Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy. Tian Y; Liao F; Wu G; Chang D; Yang Y; Dong X; Zhang Z; Zhang Y; Wu G Toxicol Mech Methods; 2015; 25(8):645-52. PubMed ID: 26108275 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways. Han M; Wang F; Gu Y; Pei X; Guo G; Yu C; Li L; Zhu M; Xiong Y; Wang Y Oncol Rep; 2016 Jan; 35(1):73-80. PubMed ID: 26531758 [TBL] [Abstract][Full Text] [Related]
28. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. Wright LE; Frye JB; Lukefahr AL; Timmermann BN; Mohammad KS; Guise TA; Funk JL J Nat Prod; 2013 Mar; 76(3):316-21. PubMed ID: 23145932 [TBL] [Abstract][Full Text] [Related]
29. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. Dunn LK; Mohammad KS; Fournier PG; McKenna CR; Davis HW; Niewolna M; Peng XH; Chirgwin JM; Guise TA PLoS One; 2009 Sep; 4(9):e6896. PubMed ID: 19727403 [TBL] [Abstract][Full Text] [Related]
30. Current perspectives on inhibitory SMAD7 in health and disease. de Ceuninck van Capelle C; Spit M; Ten Dijke P Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543 [TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of osteolytic bone metastases. Guise TA Cancer; 2000 Jun; 88(12 Suppl):2892-8. PubMed ID: 10898330 [TBL] [Abstract][Full Text] [Related]
32. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525 [TBL] [Abstract][Full Text] [Related]
33. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833 [TBL] [Abstract][Full Text] [Related]
35. Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors. Morinaga Y; Fujita N; Ohishi K; Tsuruo T Int J Cancer; 1997 May; 71(3):422-8. PubMed ID: 9139879 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway. Fu Y; Tang Y; Wang J; Guo Z Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735 [TBL] [Abstract][Full Text] [Related]
37. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma. Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402 [TBL] [Abstract][Full Text] [Related]
38. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis. Kominsky SL; Doucet M; Brady K; Weber KL J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147 [TBL] [Abstract][Full Text] [Related]
39. Inhibitor of differentiation-4 (Id4) stimulates pigmentation in melanoma leading to histiocyte infiltration. DiVito KA; Trabosh VA; Chen YS; Simbulan-Rosenthal CM; Rosenthal DS Exp Dermatol; 2015 Feb; 24(2):101-7. PubMed ID: 25363621 [TBL] [Abstract][Full Text] [Related]
40. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Nakai M; Mundy GR; Williams PJ; Boyce B; Yoneda T Cancer Res; 1992 Oct; 52(19):5395-9. PubMed ID: 1394144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]